These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 19084404

  • 1. A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.
    Evangelista T, Ferro J, Pereira P, de Carvalho M.
    Neuromuscul Disord; 2009 Jan; 19(1):66-8. PubMed ID: 19084404
    [Abstract] [Full Text] [Related]

  • 2. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
    Golightly LK, Barber GR, Barron MA, Page RL.
    Drug Metabol Drug Interact; 2013 Jan; 28(1):49-58. PubMed ID: 23314530
    [Abstract] [Full Text] [Related]

  • 3. Hyaline inclusion myopathy: unmasked by statin therapy.
    Supala-Berger A, Fine E, Heffner R, Young-McLain E.
    Muscle Nerve; 2009 Oct; 40(4):657-61. PubMed ID: 19670387
    [Abstract] [Full Text] [Related]

  • 4. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
    García-Rodríguez LA, González-Pérez A, Stang MR, Wallander MA, Johansson S.
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
    [Abstract] [Full Text] [Related]

  • 5. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC, Picksak G, Stichtenoth DO.
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [Abstract] [Full Text] [Related]

  • 6. Statin-associated myopathy with normal creatine kinase levels. Case report from a Norwegian family.
    Trøseid M, Henriksen OA, Lindal S.
    APMIS; 2005 Sep; 113(9):635-7. PubMed ID: 16218940
    [Abstract] [Full Text] [Related]

  • 7. Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.
    Goettsch WG, Heintjes EM, Kastelein JJ, Rabelink TJ, Johansson S, Herings RM.
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):435-43. PubMed ID: 16761304
    [Abstract] [Full Text] [Related]

  • 8. Presymptomatic neuromuscular disorders disclosed following statin treatment.
    Tsivgoulis G, Spengos K, Karandreas N, Panas M, Kladi A, Manta P.
    Arch Intern Med; 2006 Jul 24; 166(14):1519-24. PubMed ID: 16864763
    [Abstract] [Full Text] [Related]

  • 9. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE, Hildebrand JP, Ferguson EE, Stein JH.
    Arch Intern Med; 2006 Jul 24; 165(22):2671-6. PubMed ID: 16344427
    [Abstract] [Full Text] [Related]

  • 10. Discontinuation of statin therapy due to muscular side effects: a survey in real life.
    Rosenbaum D, Dallongeville J, Sabouret P, Bruckert E.
    Nutr Metab Cardiovasc Dis; 2013 Sep 24; 23(9):871-5. PubMed ID: 22748604
    [Abstract] [Full Text] [Related]

  • 11. [Statin therapy and muscle disorders].
    Abel T, Fehér J.
    Orv Hetil; 2009 Feb 08; 150(6):261-3. PubMed ID: 19179258
    [No Abstract] [Full Text] [Related]

  • 12. The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.
    McAfee AT, Ming EE, Seeger JD, Quinn SG, Ng EW, Danielson JD, Cutone JA, Fox JC, Walker AM.
    Pharmacoepidemiol Drug Saf; 2006 Jul 08; 15(7):444-53. PubMed ID: 16761308
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin: characterization of induced myopathy in the rat.
    Westwood FR, Scott RC, Marsden AM, Bigley A, Randall K.
    Toxicol Pathol; 2008 Feb 08; 36(2):345-52. PubMed ID: 18362199
    [Abstract] [Full Text] [Related]

  • 14. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ, Rawal B, Khan NA, Yeramaneni S, Goldenberg N, Wang P.
    Metabolism; 2009 Feb 08; 58(2):233-8. PubMed ID: 19154957
    [Abstract] [Full Text] [Related]

  • 15. Rhabdomyolysis in association with simvastatin and amiodarone.
    Roten L, Schoenenberger RA, Krähenbühl S, Schlienger RG.
    Ann Pharmacother; 2004 Jun 08; 38(6):978-81. PubMed ID: 15069169
    [Abstract] [Full Text] [Related]

  • 16. Rhabdomyolysis induced by rosuvastatin and sildenafil.
    Pennisi G, Vacante M, Russo C, Malaguarnera M.
    South Med J; 2010 Oct 08; 103(10):1052-4. PubMed ID: 20818298
    [Abstract] [Full Text] [Related]

  • 17. Managing statin myopathy.
    Venero CV, Thompson PD.
    Endocrinol Metab Clin North Am; 2009 Mar 08; 38(1):121-36. PubMed ID: 19217515
    [Abstract] [Full Text] [Related]

  • 18. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
    Duncan AJ, Hargreaves IP, Damian MS, Land JM, Heales SJ.
    Toxicol Mech Methods; 2009 Jan 08; 19(1):44-50. PubMed ID: 19778232
    [Abstract] [Full Text] [Related]

  • 19. Polysaccharide storage myopathy--case report and literature review.
    Miladi MI, Feki I, Choyakh F, Ben Hmida M, Zouari N, Mhiri C.
    Clin Neuropathol; 2005 Jan 08; 24(3):126-32. PubMed ID: 15943164
    [Abstract] [Full Text] [Related]

  • 20. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR, Jacobson TA.
    Curr Opin Lipidol; 2007 Aug 08; 18(4):401-8. PubMed ID: 17620856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.